FDA Clearance Tracker · P240009
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Last checked: Nov 19, 2026Latest source record: Oct 11, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 11, 2024
Approved
Time to decision
196 days
Received Mar 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240009
- Device name
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
- Applicant
- Contego Medical, Inc.
- Applicant location
- Raleigh, NC
- Received
- Mar 29, 2024
- Decided
- Oct 11, 2024
- Decision
- Approved
- Supplements
- 9 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
This Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection is indicated for improving the carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: Patients with symptomatic stenosis of the common or internal carotid artery with >=50% as determined by angiography using NASCET methodology, or Patients with asymptomatic stenosis of the common or internal carotid artery with >=80% as determined by angiography using NASCET methodology; Patients with reference vessel diameters 4.0 8.0 mm. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material. The Neuroguard IEP System should always be used in conjunction with an available primary distal embolic protection device as described in the IFU.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIM. The earliest in FDA's data is P040012, decided Aug 30, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Contego Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260600 · Decided Nov 4, 2026 · 253 days after receipt
Device type: Temporary Carotid Catheter For Embolic Capture (NTE) · Cardiology
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionPMA supplement
P240009-S006 · Decided Nov 4, 2026 · 401 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
K251485 · Decided Jun 13, 2025 · 30 days after receipt
Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.